{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:35:06Z","timestamp":1777296906893,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01474-2","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:34:34Z","timestamp":1777293274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exclusive Neoadjuvant Chemotherapy with the FLOT Regimen Protocol in Resectable Gastric Cancer: A Retrospective Cohort Study in a Brazilian Reference Center"],"prefix":"10.1007","volume":"57","author":[{"given":"Kelre Wannlen Campos Silva","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Carneiro","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo","family":"Stecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Roberto Naufel","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique","family":"Nocete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayssa Helena","family":"de Sena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata Medeiros","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Karoline Araujo","family":"Nonato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"Suppl 5","key":"1474_CR1","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(Suppl 5):v38\u201349.","journal-title":"Ann Oncol"},{"issue":"1","key":"1474_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"13","key":"1474_CR3","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","volume":"29","author":"M Ychou","year":"2011","unstructured":"Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715\u201321.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1474_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Von Elm","year":"2008","unstructured":"Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"1474_CR5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejso.2020.04.037","volume":"46","author":"B Geerts","year":"2020","unstructured":"Geerts B, Goense L, van Rossum PSN, et al. Pathologic complete response after preoperative FLOT chemotherapy in patients with advanced gastric cancer: predictive factors and survival analysis. Eur J Surg Oncol. 2020;46(9):1628\u201335.","journal-title":"Eur J Surg Oncol"},{"issue":"10184","key":"1474_CR6","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"SE Al-Batran","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019;393(10184):1948\u201357.","journal-title":"Lancet"},{"key":"1474_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315\u201321.","journal-title":"Lancet"},{"issue":"18","key":"1474_CR8","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"1474_CR9","first-page":"22","volume":"19","author":"TR Oliveira","year":"2023","unstructured":"Oliveira TR. Toxicidade cumulativa no regime FLOT: n\u00famero de ciclos e impacto na ades\u00e3o ao tratamento. Revista Brasileira de Oncologia Cl\u00ednica. 2023;19(1):22\u20138.","journal-title":"Revista Brasileira de Oncologia Cl\u00ednica"},{"issue":"5","key":"1474_CR10","first-page":"1456","volume":"45","author":"Y Fujiwara","year":"2021","unstructured":"Fujiwara Y, Fukuchi M, Tanioka T, et al. Predictive factors for recurrence after curative gastrectomy for advanced gastric cancer: importance of lymph node response to neoadjuvant chemotherapy. World J Surg. 2021;45(5):1456\u201364.","journal-title":"World J Surg"},{"issue":"2","key":"1474_CR11","first-page":"234","volume":"25","author":"Y Nakayama","year":"2022","unstructured":"Nakayama Y, Fujitani K, Hirao M, et al. Prolonged preoperative chemotherapy in advanced gastric cancer: impact of cycle number on survival outcomes. Gastric Cancer. 2022;25(2):234\u201343.","journal-title":"Gastric Cancer"},{"issue":"6","key":"1474_CR12","first-page":"3401","volume":"29","author":"LJ Pepenin","year":"2022","unstructured":"Pepenin LJ, Goense L, van Rossum PSN, et al. Eight cycles of neoadjuvant FLOT: feasibility, response and outcomes in resectable gastric cancer. Ann Surg Oncol. 2022;29(6):3401\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"1474_CR13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.6004\/jnccn.2016.0137","volume":"14","author":"JA Ajani","year":"2016","unstructured":"Ajani JA, D\u2019Amico TA, Almhanna K, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(10):1286\u2013312.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"1474_CR14","first-page":"498","volume":"39","author":"WL Costa","year":"2012","unstructured":"Costa WL, Coimbra FJF, Ribeiro HS, et al. Gastric cancer at the A.C. Camargo Cancer Center: historical evolution and impact of multimodal treatment. Revista do Col\u00e9gio Brasileiro de Cirurgi\u00f5es. 2012;39(6):498\u2013504.","journal-title":"Revista do Col\u00e9gio Brasileiro de Cirurgi\u00f5es"},{"key":"1474_CR15","first-page":"31","volume":"36","author":"A Mechahougui","year":"2020","unstructured":"Mechahougui A, Piessen G, Mariette C, et al. Prognostic value of pathologic complete response following neoadjuvant FLOT chemotherapy for gastric and gastroesophageal junction adenocarcinoma. Surg Oncol. 2020;36:31\u20136.","journal-title":"Surg Oncol"},{"key":"1474_CR16","first-page":"1","volume":"13","author":"K Shitara","year":"2021","unstructured":"Shitara K, Van Cutsem E, Bang YJ, et al. Neoadjuvant chemotherapy in gastric cancer: current evidence and future perspectives. Therapeutic Adv Med Oncol. 2021;13:1\u201314.","journal-title":"Therapeutic Adv Med Oncol"},{"issue":"3","key":"1474_CR17","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 5","key":"1474_CR18","first-page":"v38","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer: current management and future perspectives. Ann Oncol. 2016;27(Suppl 5):v38\u201349.","journal-title":"Ann Oncol"},{"key":"1474_CR19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134. https:\/\/doi.org\/10.1001\/jama.2013.281053.","journal-title":"JAMA"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01474-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01474-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01474-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:34:36Z","timestamp":1777293276000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01474-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01474-2","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"102"}}